Australia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung...
Read moreBristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of...
Read moreThe US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) tablets, developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly...
Read moreThe US Food and Drug Administration (FDA) has expressed concerns over the manufacturing process of at least one product at...
Read moreThe courier firm FedEx faces drug-trafficking charges after being indicted by a federal grand jury in California, in a case...
Read moreBayer has announced the US Food and Drug Administration's (FDA) approval of Eylea, an aflibercept solution for injection into the...
Read moreEisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that BELVIQ(R) (lorcaserin HCl) has been nominated by the Galien...
Read moreLSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences...
Read moreSTALLERGENES (Paris:GENP), a global healthcare company specialized in the diagnosis and treatment of allergies through allergen immunotherapy-based solutions, announced today...
Read moreAIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.